Synthesis, characterization, molecular docking evaluation, antiplatelet and anticoagulant actions of 1,2,4 triazole hydrazone and sulphonamide novel derivatives
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-153X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Synthesis, characterization, molecular docking evaluation, antiplatelet and anticoagulant actions of 1,2,4 triazole hydrazone and sulphonamide novel derivatives ; volume:12 ; number:1 ; day:7 ; month:2 ; year:2018 ; pages:1-16 ; date:12.2018
Chemistry central journal ; 12, Heft 1 (7.2.2018), 1-16, 12.2018
- Urheber
-
Khalid, Waseem
- Beteiligte Personen und Organisationen
-
Badshah, Amir
Khan, Arif-ullah
Nadeem, Humaira
Ahmed, Sagheer
SpringerLink (Online service)
- DOI
-
10.1186/s13065-018-0378-5
- URN
-
urn:nbn:de:101:1-2018090418581113714307
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khalid, Waseem
- Badshah, Amir
- Khan, Arif-ullah
- Nadeem, Humaira
- Ahmed, Sagheer
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Hydrazone.
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Synthesis and Antimicrobial Activity of Novel Hydrazone and 1,2,4-Triazole-3-thione Derivatives
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Cyclopentadienone-hydrazone
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Hydrazone.
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Synthesis and Antimicrobial Activity of Novel Hydrazone and 1,2,4-Triazole-3-thione Derivatives
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Cyclopentadienone-hydrazone
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Hydrazone.
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Synthesis and Antimicrobial Activity of Novel Hydrazone and 1,2,4-Triazole-3-thione Derivatives
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Cyclopentadienone-hydrazone